Biodesix (BDSX) EBIT Margin (2019 - 2026)
Biodesix's (BDSX) quarterly EBIT Margin came in at 24.27% in Q1 2026, up 2661.0% YoY from 0.88% in Q1 2025, and down 254.73% on a QoQ basis from 6.84% in Q4 2025.
Biodesix (BDSX) EBIT Margin (2019 - 2026) Analysis & Trends
Biodesix (BDSX) has 8 years of EBIT Margin data on file, last reported at 24.27% in Q1 2026.
- Quarterly EBIT Margin rose 2661.0% year-over-year to 24.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25.95% (up 1785.0% YoY) and the FY2025 annual result came in at 31.5%, up 1687.0% from the prior year.
- EBIT Margin fell to 24.27% in Q1 2026, from 6.84% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 6.84% in Q4 2025 to a low of 220.85% in Q1 2022.
- A 5-year average of 76.65% and a median of 50.87% in 2025 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin plunged 20150 bps — and 2024, when it jumped 10642 bps.
- Tracing BDSX's EBIT Margin over 5 years: stood at 144.58% in 2022, then jumped by 68 bps to 46.84% in 2023, then soared by 31 bps to 32.55% in 2024, then surged by 79 bps to 6.84% in 2025, then plunged by 255 bps to 24.27% in 2026.
- The last three EBIT Margin figures came in at 24.27% (Q1 2026), 6.84% (Q4 2025), and 32.39% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 15.08% |
| 10 | Biodesix | 220.06 Mn | 194.49 Mn | 21.35 Mn | -24.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.27% |
| Dec 31, 2025 | -6.84% |
| Sep 30, 2025 | -32.39% |
| Jun 30, 2025 | -48.55% |
| Mar 31, 2025 | -50.87% |
| Dec 31, 2024 | -32.55% |
| Sep 30, 2024 | -47.33% |
| Jun 30, 2024 | -45.95% |
| Mar 31, 2024 | -74.38% |
| Dec 31, 2023 | -46.84% |
| Sep 30, 2023 | -53.16% |
| Jun 30, 2023 | -92.04% |
| Mar 31, 2023 | -180.80% |
| Dec 31, 2022 | -144.58% |
| Sep 30, 2022 | -95.53% |
| Jun 30, 2022 | -106.17% |
| Mar 31, 2022 | -220.85% |
| Dec 31, 2021 | -161.67% |
| Sep 30, 2021 | -200.44% |
| Jun 30, 2021 | -89.08% |